Though the month of December and the holidays saw markets slow, the last few days of market activity seem to suggest that is changing. The increased activity in larger markets has shown that investor interest in the market is returning.
As the larger markets see some gains, so too will the smaller and more speculative stocks. 2023 is shaping up to be a promising year for cheaper stocks. According to data from Thomson Reuters, the median penny stock, which is defined as stocks trading under $5, now has a forward P/E ratio of only 9.8X, compared to 12X a year ago.
These four stocks have had favorable starts to the year thus far, and as momentum is king in the smaller stocks, let’s take a look at some companies that are building energy to start off the new year.
InnovaQor (OTC: VMCS) is a medical management software company offering innovative technology and software solutions for the medical sector. The VMCS software platform currently includes:
– M2Pro, a custom built, cloud based, electronic health record for ambulatory physician practices
– ClinLab, a turnkey client/server lab information system for mid-range laboratories
– Qira, a healthcare business analytics tool
– MedTuning which provides clinical decision support for physicians and personalized drug treatment for patients
– Advantage, a proprietary health insurance portability and accountability act compliant software to eliminate the need for paper requisitions.
On top of their current products, the company is also developing a new social media network for professionals within the medical industry. The specialized platform for global contacts among healthcare peers would allow VMCS to add subscription services for more communication and value-added specialty services.
VMCS is focused on monetizing its already-developed proprietary medical software, such as Electronic Health Records (EHR) and MedTuning. A larger investment from the company in the sales and marketing of these two sectors could result in significant volume gains and profit from these products.
Given that the Medical Management Software Sector is expected to grow at a CAGR of 5.69% between now and 2027, going from $22.6 billion to $31.9 billion, getting in on this one early could be a difference maker.
XCPCNL Business Services Corporation (OTC Pink: XCPL) is a Delaware-based corporation that operates through its wholly owned subsidiary, XCPCNL Business Corp. The company is a venture development business that leverages knowledge, skill, and experience in the consumer products industry.
Just before the holidays, the company released a statement in which XCPL said they were excited to announce the successful closing of Centiment Capital IO. The following
were included in the closing:
– Filmfundrr – a full service film production software and service
– Mantis Prime – a proprietary emotional search engine that utilizes neurodata, machine learning, and artificial intelligence to sense and predict emotional responses within any number of categories.
Investors seemed to appreciate the trimming of the fat conducted by XCPL, as the stock saw 57.14% gains on Tuesday, bringing the price up to $0.0011. With a big push like that, this may be a stock to put on your radar.
Star Alliance International Corp. (OTC: STAL) acquires and develops gold and other mining properties worldwide. STAL holds interest in the Troy mining property, which includes 78 gold mining claims covering about 4,800 acres located in Mariposa County, California.
Last year, Star Alliance entered into binding letters of intent to acquire a 51% controlling interest in Genesis. Genesis is an environmentally safe gold and other complex mineral extraction process. Genesis technology is game-changing in how it extracts gold and other minerals from oxide and other complex ores.
The company also signed a binding letter of intent to acquire a 51 percent interest in both gold and lithium mines in Nigeria.
STAL rose 55.56% to a share price of $0.042 on Tuesday. Big numbers like that should certainly get the attention of investors.
Ozop Energy Solutions, Inc. (OTC: OZSC) is a company that invents, designs, develops, manufactures, and distributes renewable energy products. The company also designs and constructs electrically generating PV systems, provides electric vehicle chargers, and distributes various equipment related to the solar field.
Last week, the company announced it had signed a multi-year contract with Cirba Solutions, a leading provider of battery management and materials processing services for end-of-life batteries. The agreement creates a pathway for OZSC to offer a complete battery recycling program through its extensive dealership network.
OZSC saw increased investor activity on Tuesday, with the stock finding itself at $0.0015, up 23.81%. With a great start to the week, be sure to put this one on your watchlist for potential gainers.
Disclaimers: This article contains sponsored content.The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled. Capital Gains Report ‘CGR’ is responsible for the production and distribution of this content. CGR is not operated by a licensed broker, a dealer, or a registered investment adviser. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. CGR authors, contributors, or its agents, may be compensated for preparing research, video graphics, and editorial content. CGR has been compensated to produce and syndicate content related to VMCS. As part of that content, readers, subscribers, and website viewers, are expected to read the full disclaimers and financial disclosures statement that can be found on our website.